LSTA - Lisata Therapeutics Inc.
Lisata Therapeutics Inc. Logo

LSTA - Lisata Therapeutics Inc.

https://www.lisata.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.

52W High
$4.20
52W Low
$1.87
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.01
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.82
EV/Revenue (<3 favorable)
0.32
P/S (TTM) (<3 favorable)
17.76
P/B (<3 favorable)
0.89
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
19.82%
Institutions (25–75% balanced)
8.94%
Shares Outstanding
8,598,200
Float
7,259,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
1,070,000
Gross Profit (TTM)
1,070,000
EPS (TTM)
-2.23
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-69.54%
ROE (TTM) (>15% strong)
-0.64%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.1224
Previous
-0.1229
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025